Antidepressant medications have been in general use since the late 1950s. Many patients are treated as outpatients and often continue with their normal routines during treatment. Individuals may undertake activities where any change in memory functioning, negative or positive, might have important c
Intravenous antidepressants: A review
β Scribed by Nidal J. Moukaddam; Robert M.A. Hirschfeld
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 92 KB
- Volume
- 19
- Category
- Article
- ISSN
- 1091-4269
- DOI
- 10.1002/da.10135
No coin nor oath required. For personal study only.
β¦ Synopsis
Antidepressant medications have an onset of action of several weeks and have moderate efficacy. Their mode of administration is oral (p.o.). Some clinicians wondered whether intravenous (i.v.) administration would speed onset of action and increase efficacy. In this article we review controlled studies on i.v. administration of antidepressants. These include clomipramine, citalopram, and other antidepressants. Overall these studies do not support increased efficacy of i.v. over p.o.administration but there are suggestions of a faster onset of action. In one study i.v. citalopram showed superior response rates over p.o. citalopram (79% vs. 63%) in severely depressed patients at 8 weeks.
π SIMILAR VOLUMES
## In an era of constrained health care financing, clinicians are increasingly faced with considering the economic consequences in addition to the clinical outcomes associated with initiating a patient on antidepressant therapy. This has increased the demand for health economic studies comparing ant
## Abstract ## Objectives The literature exploring the role that cytokine functioning plays in the pathogenesis and treatment of depressive illness is reviewed. The review focuses on the influence of antidepressants on cytokines, and on how treatment response might be affected by genetic variants